AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 33974564 — intervention group
Group type: EXPERIMENTAL
Intervention: Mesenchymal stromal cells (MSCs)
Number of subjects: 27
Study 33974564 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 27
Study 33974564 — intervention group
Group type: EXPERIMENTAL
Intervention: Airspace Ang-2
Number of subjects: 27
Study 33974564 — intervention group
Group type: EXPERIMENTAL
Intervention: Airspace receptor for advanced glycation end-products (RAGE)
Number of subjects: 27
Study 33322192 — intervention group
Group type: EXPERIMENTAL
Intervention: Latanoprost once a day
Number of subjects: 86
Study 33322192 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined preparation of brimonidine and timolol BID
Number of subjects: 86
Study 33322192 — intervention group
Group type: COMPARATOR
Intervention: Control group (no topical hypotensive treatment)
Number of subjects: 86
Study 35082139 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D (2000 IU/day)
Number of subjects: 25871
Study 35082139 — intervention group
Group type: EXPERIMENTAL
Intervention: Omega 3 fatty acids (1000 mg/day)
Number of subjects: 25871
Study 35082139 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D and omega 3 fatty acids
Number of subjects: 25871
Study 35082139 — intervention group
Group type: EXPERIMENTAL
Intervention: Only Vitamin D
Number of subjects: 25871
Study 35082139 — intervention group
Group type: EXPERIMENTAL
Intervention: Only Omega 3 fatty acids
Number of subjects: 25871
Study 35082139 — intervention group
Group type: COMPARATOR
Intervention: Vitamin D placebo and omega 3 fatty acid placebo
Number of subjects: 25871
Study 33638016 — intervention group
Group type: EXPERIMENTAL
Intervention: Vibration foam roll (VFR)
Number of subjects: 21
Study 33638016 — intervention group
Group type: COMPARATOR
Intervention: Non-vibration foam roll (NVFR)
Number of subjects: 21
Study 35242500 — intervention group
Group type: EXPERIMENTAL
Intervention: 12-month lifestyle intervention (interactive web-based behavioral intervention)
Number of subjects: 300
Study 35242500 — intervention group
Group type: COMPARATOR
Intervention: Non-PE control group
Number of subjects: 300
Study 33652763 — intervention group
Group type: EXPERIMENTAL
Intervention: Multi-strain probiotic (Lactobacillus, Bifidobacterium, and Streptococcus thermophilus) for eight weeks
Number of subjects: 0
Study 33652763 — intervention group
Group type: COMPARATOR
Intervention: Placebo for eight weeks
Number of subjects: 0
Study 35744008 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultra-hypofractionated whole-breast 3D conformal radiotherapy of 26 Gy in 5 fractions over 1 week
Number of subjects: 60
Study 34559956 — intervention group
Group type: EXPERIMENTAL
Intervention: LCP-Tac
Number of subjects: 9
Study 34559956 — intervention group
Group type: COMPARATOR
Intervention: PR-Tac
Number of subjects: 9
Study 35848770 — intervention group
Group type: EXPERIMENTAL
Intervention: 3D virtual reality models for surgical planning
Number of subjects: 92
Study 35848770 — intervention group
Group type: EXPERIMENTAL
Intervention: 3D virtual reality models for surgical planning (subset with modified operative plan)
Number of subjects: 92
Study 35848770 — intervention group
Group type: COMPARATOR
Intervention: Usual preoperative planning with prostate biopsy results and MRI only (Control)
Number of subjects: 92
Study 32325006 — intervention group
Group type: EXPERIMENTAL
Intervention: Instagram posts regarding antidepressant use
Number of subjects: 13096
Study 32325006 — intervention group
Group type: EXPERIMENTAL
Intervention: Posts mentioning psychotherapy, comorbidities, or polypharmacy
Number of subjects: 13096
Study 32325006 — intervention group
Group type: EXPERIMENTAL
Intervention: Instagram posts overall
Number of subjects: 13096
Study 32077729 — intervention group
Group type: EXPERIMENTAL
Intervention: Tuning in to Teens (TINT) program, a 6-session intervention targeting parent emotion awareness/regulation, parental beliefs about emotion, and parents' emotion coaching skills.
Number of subjects: 225
Study 32077729 — intervention group
Group type: COMPARATOR
Intervention: Control condition (not specified in detail).
Number of subjects: 225
Study 36505196 — intervention group
Group type: EXPERIMENTAL
Intervention: C-MAC video-laryngoscope
Number of subjects: 150
Study 36505196 — intervention group
Group type: COMPARATOR
Intervention: Miller laryngoscope
Number of subjects: 150
Study 34732660 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination treatment (COM) - MET 500 mg TID, exenatide 2 mg QW
Number of subjects: 50
Study 34732660 — intervention group
Group type: COMPARATOR
Intervention: Metformin (MET) - 500 mg three times a day (TID)
Number of subjects: 50
Study 34525105 — intervention group
Group type: EXPERIMENTAL
Intervention: Online Life Story Book (OLSB) intervention
Number of subjects: 42
Study 34525105 — intervention group
Group type: COMPARATOR
Intervention: Wait list control condition
Number of subjects: 42
Study 33292973 — intervention group
Group type: EXPERIMENTAL
Intervention: Bacterial phytase supplementation
Number of subjects: 270
Study 33292973 — intervention group
Group type: EXPERIMENTAL
Intervention: Fungal phytase supplementation
Number of subjects: 270
Study 33292973 — intervention group
Group type: COMPARATOR
Intervention: Control diet
Number of subjects: 270
Study 33292973 — intervention group
Group type: EXPERIMENTAL
Intervention: Phytase dosages (450 and 900 FTU)
Number of subjects: 270
Study 35149642 — intervention group
Group type: EXPERIMENTAL
Intervention: Interactive Spaced Education (ISE/QI)
Number of subjects: 101
Study 35149642 — intervention group
Group type: COMPARATOR
Intervention: Standard Education (STD/QI)
Number of subjects: 101
Study 35149642 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall population
Number of subjects: 101
Study 33621804 — intervention group
Group type: EXPERIMENTAL
Intervention: MPS-PWUD scale (9-item scale with two components)
Number of subjects: 164
Study 33621804 — intervention group
Group type: EXPERIMENTAL
Intervention: Enacted stigma (6 items)
Number of subjects: 164
Study 33621804 — intervention group
Group type: EXPERIMENTAL
Intervention: Internalized stigma (3 items)
Number of subjects: 164
Study 32880847 — intervention group
Group type: EXPERIMENTAL
Intervention: Local Vibration (LV) - frequency 80 Hz; amplitude 1 mm
Number of subjects: 21
Study 32880847 — intervention group
Group type: EXPERIMENTAL
Intervention: Local Vibration (LV)
Number of subjects: 21
Study 32880847 — intervention group
Group type: COMPARATOR
Intervention: Whole-body Vibration (WBV) - frequency 30 Hz; amplitude 2 mm
Number of subjects: 21
Study 35103951 — intervention group
Group type: EXPERIMENTAL
Intervention: Faster insulin aspart (FIA)
Number of subjects: 117
Study 34959919 — intervention group
Group type: EXPERIMENTAL
Intervention: Graphic beverage health warning labels
Number of subjects: 262
Study 34959919 — intervention group
Group type: EXPERIMENTAL
Intervention: Beverage sugar content information
Number of subjects: 262
Study 34959919 — intervention group
Group type: COMPARATOR
Intervention: Attention control
Number of subjects: 262
Study 33463052 — intervention group
Group type: EXPERIMENTAL
Intervention: PSORI-CM01
Number of subjects: 29
Study 33463052 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 29
Study 35362766 — intervention group
Group type: EXPERIMENTAL
Intervention: Salmon fish protein supplement
Number of subjects: 88
Study 35362766 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 88
Study 33691517 — intervention group
Group type: EXPERIMENTAL
Intervention: Brexpiprazole (2–4 mg/day)
Number of subjects: 381
Study 33691517 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 381
Study 33691517 — intervention group
Group type: EXPERIMENTAL
Intervention: Brexpiprazole (in open-label study)
Number of subjects: 381
Study 33691517 — intervention group
Group type: EXPERIMENTAL
Intervention: Brexpiprazole
Number of subjects: 381
Study 32716303 — intervention group
Group type: EXPERIMENTAL
Intervention: mHealth app intervention
Number of subjects: 100
Study 32716303 — intervention group
Group type: COMPARATOR
Intervention: Routine health care and instruction
Number of subjects: 100
Study 35728840 — intervention group
Group type: COMPARATOR
Intervention: Perineural dexamethasone (2 mg)
Number of subjects: 50
Study 35728840 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined perineural dexamethasone (2 mg)‐dexmedetomidine (50 µg)
Number of subjects: 50
Study 34776182 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture-like TENS (AL-TENS)
Number of subjects: 60
Study 34776182 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional TENS (C-TENS)
Number of subjects: 60
Study 34776182 — intervention group
Group type: COMPARATOR
Intervention: Sham TENS (S-TENS)
Number of subjects: 60
Study 32518042 — intervention group
Group type: EXPERIMENTAL
Intervention: Quetiapine XR 300 mg once daily
Number of subjects: 322
Study 32518042 — intervention group
Group type: EXPERIMENTAL
Intervention: Quetiapine XR 150 mg once daily
Number of subjects: 322
Study 32518042 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 322
Study 35181846 — intervention group
Group type: EXPERIMENTAL
Intervention: BVERS only
Number of subjects: 14
Study 35181846 — intervention group
Group type: EXPERIMENTAL
Intervention: BVERS + PC
Number of subjects: 14
Study 35181846 — intervention group
Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 14
Study 33604690 — intervention group
Group type: EXPERIMENTAL
Intervention: 177Lu-DOTATATE (27.5 GBq cumulative activity divided in five cycles of 5.5 GBq each every 8 weeks) plus metronomic capecitabine (1000–1500 mg daily during inter-cycle period)
Number of subjects: 37
Study 33604690 — intervention group
Group type: EXPERIMENTAL
Intervention: 177Lu-DOTATATE plus metronomic capecitabine
Number of subjects: 37
Study 36127094 — intervention group
Group type: EXPERIMENTAL
Intervention: TEMPiS-Flying Intervention Team (TEMPiS-FIT)
Number of subjects: 0
Study 36127094 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 0
Study 33645407 — intervention group
Group type: EXPERIMENTAL
Intervention: 28-compartment pillbox
Number of subjects: 190
Study 33645407 — intervention group
Group type: COMPARATOR
Intervention: Control group (no pillbox)
Number of subjects: 190
Study 34930790 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmacy-led intervention (two personalised sessions addressing negative treatment beliefs and action planning)
Number of subjects: 56
Study 34930790 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 56
Study 34342019 — intervention group
Group type: EXPERIMENTAL
Intervention: Small for gestational age (SGA)
Number of subjects: 737
Study 34342019 — intervention group
Group type: EXPERIMENTAL
Intervention: Fetal alcohol syndrome (FAS)
Number of subjects: 737
Study 34342019 — intervention group
Group type: EXPERIMENTAL
Intervention: Partial FAS
Number of subjects: 737
Study 34342019 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol-related neurodevelopmental disorder
Number of subjects: 737
Study 34342019 — intervention group
Group type: COMPARATOR
Intervention: Preterm birth
Number of subjects: 737
Study 34342019 — intervention group
Group type: COMPARATOR
Intervention: Both preterm and SGA
Number of subjects: 737
Study 36329227 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D3 supplementation (60,000 IU weekly followed by 5000 IU daily)
Number of subjects: 110
Study 36329227 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 110
Study 36329227 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D3 supplementation
Number of subjects: 110
Study 34090255 — intervention group
Group type: EXPERIMENTAL
Intervention: IV ketamine
Number of subjects: 56
Study 34090255 — intervention group
Group type: COMPARATOR
Intervention: IV midazolam (placebo)
Number of subjects: 56
Study 32842722 — intervention group
Group type: EXPERIMENTAL
Intervention: Femoral nerve block with 2% chloroprocaine
Number of subjects: 16
Study 32842722 — intervention group
Group type: COMPARATOR
Intervention: Saline sham (control)
Number of subjects: 16
Study 35066133 — intervention group
Group type: EXPERIMENTAL
Intervention: Riboflavin Photosensitizer (RF)
Number of subjects: 40
Study 35066133 — intervention group
Group type: COMPARATOR
Intervention: Silver Diamine Fluoride (SDF)
Number of subjects: 40
Study 35066133 — intervention group
Group type: EXPERIMENTAL
Intervention: Photon Induced Photoacoustic Streaming (PIPS)
Number of subjects: 40
Study 35066133 — intervention group
Group type: EXPERIMENTAL
Intervention: Diode Laser
Number of subjects: 40
Study 34536993 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided bilateral superficial cervical plexus block (BSCPB) with 7.5 ml of ropivacaine 0.5% on each side
Number of subjects: 82
Study 34536993 — intervention group
Group type: COMPARATOR
Intervention: Control group (CON) with equal amount of 0.9% normal saline
Number of subjects: 82
Study 35807888 — intervention group
Group type: EXPERIMENTAL
Intervention: Mother's Own Milk with fortification (F-MOM)
Number of subjects: 214
Study 35807888 — intervention group
Group type: EXPERIMENTAL
Intervention: Mother's Own Milk without fortification (U-MOM)
Number of subjects: 214
Study 35807888 — intervention group
Group type: COMPARATOR
Intervention: Preterm Formula (PF-group)
Number of subjects: 214
Study 33904275 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiation doses
Number of subjects: 757
Study 33904275 — intervention group
Group type: EXPERIMENTAL
Intervention: T classification
Number of subjects: 757
Study 33904275 — intervention group
Group type: EXPERIMENTAL
Intervention: Mandibular surgery
Number of subjects: 757
Study 33904275 — intervention group
Group type: EXPERIMENTAL
Intervention: Periodontitis
Number of subjects: 757
Study 33904275 — intervention group
Group type: EXPERIMENTAL
Intervention: Diabetes
Number of subjects: 757
Study 33904275 — intervention group
Group type: EXPERIMENTAL
Intervention: Tooth extraction after radiotherapy
Number of subjects: 757
Study 33904275 — intervention group
Group type: EXPERIMENTAL
Intervention: Dental caries
Number of subjects: 757
Study 33904275 — intervention group
Group type: EXPERIMENTAL
Intervention: Periapical periodontitis
Number of subjects: 757
Study 33904275 — intervention group
Group type: EXPERIMENTAL
Intervention: Smoking
Number of subjects: 757
Study 33904275 — intervention group
Group type: EXPERIMENTAL
Intervention: Unilateral/bilateral radiotherapy
Number of subjects: 757
Study 32933552 — intervention group
Group type: EXPERIMENTAL
Intervention: Licorice-based herbal preparation (D-Reglis ®) at a dose of 760 mg three times a day for seven days
Number of subjects: 60
Study 32933552 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment for COVID-19 based on the Iranian Ministry of Health and Medical Education's protocol for seven days
Number of subjects: 60
Study 32933552 — intervention group
Group type: EXPERIMENTAL
Intervention: Licorice-based herbal preparation (D-Reglis ®)
Number of subjects: 60
Study 32933552 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment for COVID-19
Number of subjects: 60
Study 35202848 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin (25mg/cat PO/q24h for 30 days)
Number of subjects: 28
Study 35202848 — intervention group
Group type: EXPERIMENTAL
Intervention: Obesity and diabetes mellitus (O&D) adjuvant diet (Equilíbrio O&D, Total Alimentos ADM)
Number of subjects: 28
Study 35202848 — intervention group
Group type: COMPARATOR
Intervention: Methylprednisolone acetate (20 mg intramuscularly)
Number of subjects: 28
Study 33137161 — intervention group
Group type: EXPERIMENTAL
Intervention: Ramelteon (8 mg/day on the day before surgery and on postoperative days 1 to 3)
Number of subjects: 306
Study 33137161 — intervention group
Group type: COMPARATOR
Intervention: Control (no ramelteon administration)
Number of subjects: 306
Study 35977836 — intervention group
Group type: EXPERIMENTAL
Intervention: ubrogepant 50 mg
Number of subjects: 808
Study 35977836 — intervention group
Group type: EXPERIMENTAL
Intervention: ubrogepant 100 mg
Number of subjects: 808
Study 35977836 — intervention group
Group type: COMPARATOR
Intervention: usual care
Number of subjects: 808
Study 33458787 — intervention group
Group type: EXPERIMENTAL
Intervention: Aligner
Number of subjects: 117
Study 33458787 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall
Number of subjects: 117
Study 35295331 — intervention group
Group type: COMPARATOR
Intervention: Carbocysteine oral solution (mint taste)
Number of subjects: 42
Study 35295331 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbocysteine oral solution (strawberry taste)
Number of subjects: 42
Study 33277607 — intervention group
Group type: EXPERIMENTAL
Intervention: 810 nm diode laser application as an adjunct to non-surgical periodontal therapy (NPT)
Number of subjects: 25
Study 33277607 — intervention group
Group type: COMPARATOR
Intervention: Non-surgical periodontal therapy (NPT) without diode laser
Number of subjects: 25
Study 36062762 — intervention group
Group type: EXPERIMENTAL
Intervention: Delta radiomics based on dual-energy computed tomography (DECT) images
Number of subjects: 103
Study 36062762 — intervention group
Group type: EXPERIMENTAL
Intervention: Optimal radiomics signature (RS) from the delta model
Number of subjects: 103
Study 32681350 — intervention group
Group type: EXPERIMENTAL
Intervention: Urinary catheter valve
Number of subjects: 97
Study 32681350 — intervention group
Group type: COMPARATOR
Intervention: Continuous bladder drainage
Number of subjects: 97
Study 33026937 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibrutinib
Number of subjects: 804
Study 32591590 — intervention group
Group type: EXPERIMENTAL
Intervention: mCIMT + AOT (n=20)
Number of subjects: 36
Study 32591590 — intervention group
Group type: COMPARATOR
Intervention: mCIMT + placebo (n=16)
Number of subjects: 36
Study 36345020 — intervention group
Group type: EXPERIMENTAL
Intervention: Radial extracorporeal shock wave therapy (ESWT)
Number of subjects: 38
Study 36345020 — intervention group
Group type: COMPARATOR
Intervention: Sham extracorporeal shock wave therapy (sham‐ESWT)
Number of subjects: 38
Study 33506306 — intervention group
Group type: EXPERIMENTAL
Intervention: Text message plus HIV self-testing (HIVST) service (n=250)
Number of subjects: 491
Study 33506306 — intervention group
Group type: COMPARATOR
Intervention: Standard of care arm (text message promoting HIV testing every 3 months) (n=241)
Number of subjects: 491
Study 33379551 — intervention group
Group type: EXPERIMENTAL
Intervention: Randomized probe imaging (RPI) using visible light
Number of subjects: 0
Study 33379551 — intervention group
Group type: EXPERIMENTAL
Intervention: Randomized probe imaging (RPI) using soft X-rays
Number of subjects: 0
Study 33379551 — intervention group
Group type: COMPARATOR
Intervention: Randomized probe imaging (RPI)
Number of subjects: 0
Study 70651249 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylactic retention suture
Number of subjects: 300
Study 70651249 — intervention group
Group type: COMPARATOR
Intervention: Control (running looped #1 Nylon suture)
Number of subjects: 300
Study 35162339 — intervention group
Group type: EXPERIMENTAL
Intervention: Yohimbine hydrochloride (YHM; 2.5 mg)
Number of subjects: 18
Study 35162339 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PL; gluten-free corn starch)
Number of subjects: 18
Study 33414482 — intervention group
Group type: EXPERIMENTAL
Intervention: Nilotinib 300 mg BID
Number of subjects: 0
Study 33414482 — intervention group
Group type: EXPERIMENTAL
Intervention: Nilotinib 400 mg BID
Number of subjects: 0
Study 33414482 — intervention group
Group type: COMPARATOR
Intervention: Imatinib 400 mg QD
Number of subjects: 0
Study 32678438 — intervention group
Group type: EXPERIMENTAL
Intervention: Bevacizumab
Number of subjects: 44
Study 32678438 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 44
Study 34817542 — intervention group
Group type: EXPERIMENTAL
Intervention: Rehabilitation intervention
Number of subjects: 349
Study 34817542 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 349
Study 33184024 — intervention group
Group type: EXPERIMENTAL
Intervention: ICS + LABA
Number of subjects: 303
Study 33184024 — intervention group
Group type: EXPERIMENTAL
Intervention: ICS + LABA + LAMA
Number of subjects: 303
Study 32167483 — intervention group
Group type: EXPERIMENTAL
Intervention: PainCoach app
Number of subjects: 71
Study 32167483 — intervention group
Group type: EXPERIMENTAL
Intervention: PainCoach app (active use subgroup)
Number of subjects: 71
Study 32167483 — intervention group
Group type: COMPARATOR
Intervention: Control group (usual care)
Number of subjects: 71
Study 32852242 — intervention group
Group type: EXPERIMENTAL
Intervention: CAST‐6 screening test
Number of subjects: 3000
Study 33036995 — intervention group
Group type: EXPERIMENTAL
Intervention: Load management intervention based on ACWR principles for 10 months
Number of subjects: 482
Study 33036995 — intervention group
Group type: COMPARATOR
Intervention: Control group (normal training planning)
Number of subjects: 482
Study 32192595 — intervention group
Group type: EXPERIMENTAL
Intervention: Dienogest (1 mg/day, orally)
Number of subjects: 94
Study 32192595 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 94
Study 35500144 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 72
Study 35500144 — intervention group
Group type: EXPERIMENTAL
Intervention: 2-row V/2-row T (2V/2T)
Number of subjects: 72
Study 35500144 — intervention group
Group type: EXPERIMENTAL
Intervention: 2-row V/3-row T (2V/3T)
Number of subjects: 72
Study 35500144 — intervention group
Group type: EXPERIMENTAL
Intervention: 3-row V/2-row T (3V/2T)
Number of subjects: 72
Study 35500144 — intervention group
Group type: EXPERIMENTAL
Intervention: 3-row V/3-row T (3V/3T)
Number of subjects: 72
Study 35500144 — intervention group
Group type: EXPERIMENTAL
Intervention: FEESAs (all groups)
Number of subjects: 72
Study 35500144 — intervention group
Group type: EXPERIMENTAL
Intervention: 3-row V/3-row T vs 2-row V/2-row T
Number of subjects: 72
Study 35500144 — intervention group
Group type: EXPERIMENTAL
Intervention: Initial leakage location
Number of subjects: 72
Study 34018147 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined lipid-lowering therapy (10 mg/day atorvastatin and 10 mg/day ezetimibe)
Number of subjects: 200
Study 34018147 — intervention group
Group type: COMPARATOR
Intervention: Intensive statin regimen (40 mg/day atorvastatin)
Number of subjects: 200
Study 36170636 — intervention group
Group type: EXPERIMENTAL
Intervention: Standardized criteria for inpatient palliative care (PC) consultation
Number of subjects: 0
Study 36170636 — intervention group
Group type: EXPERIMENTAL
Intervention: Triggered inpatient PC consult
Number of subjects: 0
Study 34515341 — intervention group
Group type: EXPERIMENTAL
Intervention: Reflexology (DR-1)
Number of subjects: 300
Study 34515341 — intervention group
Group type: EXPERIMENTAL
Intervention: Meditative practices (DR-2)
Number of subjects: 300